ASCO26: Michael Hassett, MD, MPH, eSyM

Dr. Michael Hassett of Dana-Farber Cancer Institute shared new findings showing deployment of eSyM, an ePRO-based, EHR-integrated symptom management program, was associated with statistically significant and potentially meaningful improvements in overall survival. Strategies to improve adoption of ePRO-based symptom management may be warranted.

July 1, 2026

Dana-Farber

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Oncology
#3

Cleveland Clinic Lerner College of Medicine

Cleveland, OH
Key Differentiators
- Oncology
#4

Harvard Medical School

Boston, MA
Key Differentiators
- Oncology
#5

George Washington University Medical Center

Washington, DC
Key Differentiators
- Oncology